nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ABCG2—Topotecan—cervical cancer	0.352	0.634	CbGbCtD
Tamoxifen—ABCB1—Topotecan—cervical cancer	0.127	0.229	CbGbCtD
Tamoxifen—CYP3A4—Topotecan—cervical cancer	0.0761	0.137	CbGbCtD
Tamoxifen—Tumour pain—Topotecan—cervical cancer	0.0413	0.226	CcSEcCtD
Tamoxifen—Metastatic neoplasm—Topotecan—cervical cancer	0.0203	0.111	CcSEcCtD
Tamoxifen—CYP19A1—semen—cervical cancer	0.00903	0.04	CbGeAlD
Tamoxifen—Myelosuppression—Topotecan—cervical cancer	0.0083	0.0455	CcSEcCtD
Tamoxifen—Febrile neutropenia—Topotecan—cervical cancer	0.00647	0.0355	CcSEcCtD
Tamoxifen—Pelvic pain—Topotecan—cervical cancer	0.0064	0.0351	CcSEcCtD
Tamoxifen—EBPL—epithelium—cervical cancer	0.00632	0.028	CbGeAlD
Tamoxifen—EBP—uterine cervix—cervical cancer	0.00601	0.0266	CbGeAlD
Tamoxifen—Interstitial lung disease—Topotecan—cervical cancer	0.0055	0.0301	CcSEcCtD
Tamoxifen—EBP—uterus—cervical cancer	0.00501	0.0222	CbGeAlD
Tamoxifen—SULT1A1—renal system—cervical cancer	0.00466	0.0206	CbGeAlD
Tamoxifen—EBP—female reproductive system—cervical cancer	0.0045	0.0199	CbGeAlD
Tamoxifen—EBPL—female gonad—cervical cancer	0.00427	0.0189	CbGeAlD
Tamoxifen—Blood bilirubin increased—Topotecan—cervical cancer	0.00412	0.0225	CcSEcCtD
Tamoxifen—UGT1A4—renal system—cervical cancer	0.00406	0.018	CbGeAlD
Tamoxifen—Bone pain—Topotecan—cervical cancer	0.00406	0.0223	CcSEcCtD
Tamoxifen—Pulmonary embolism—Topotecan—cervical cancer	0.00389	0.0213	CcSEcCtD
Tamoxifen—SULT1A1—female reproductive system—cervical cancer	0.00373	0.0165	CbGeAlD
Tamoxifen—DHCR7—uterine cervix—cervical cancer	0.00354	0.0157	CbGeAlD
Tamoxifen—FMO1—uterine cervix—cervical cancer	0.00354	0.0157	CbGeAlD
Tamoxifen—Neoplasm—Topotecan—cervical cancer	0.00352	0.0193	CcSEcCtD
Tamoxifen—ESRRA—uterine cervix—cervical cancer	0.00349	0.0154	CbGeAlD
Tamoxifen—SULT1A1—female gonad—cervical cancer	0.00339	0.015	CbGeAlD
Tamoxifen—Sepsis—Topotecan—cervical cancer	0.00338	0.0185	CcSEcCtD
Tamoxifen—SULT1A1—vagina—cervical cancer	0.00337	0.0149	CbGeAlD
Tamoxifen—ESRRA—decidua—cervical cancer	0.00332	0.0147	CbGeAlD
Tamoxifen—FMO1—renal system—cervical cancer	0.00331	0.0147	CbGeAlD
Tamoxifen—ESRRA—renal system—cervical cancer	0.00326	0.0144	CbGeAlD
Tamoxifen—FMO1—endometrium—cervical cancer	0.0032	0.0142	CbGeAlD
Tamoxifen—ESRRA—endometrium—cervical cancer	0.00315	0.014	CbGeAlD
Tamoxifen—DHCR7—mammalian vulva—cervical cancer	0.0031	0.0137	CbGeAlD
Tamoxifen—FMO1—mammalian vulva—cervical cancer	0.0031	0.0137	CbGeAlD
Tamoxifen—ESRRA—mammalian vulva—cervical cancer	0.00305	0.0135	CbGeAlD
Tamoxifen—Dermatitis bullous—Topotecan—cervical cancer	0.00296	0.0162	CcSEcCtD
Tamoxifen—ESRRA—uterus—cervical cancer	0.00291	0.0129	CbGeAlD
Tamoxifen—EBPL—lymph node—cervical cancer	0.00275	0.0122	CbGeAlD
Tamoxifen—FMO3—mammalian vulva—cervical cancer	0.00268	0.0119	CbGeAlD
Tamoxifen—DHCR7—female reproductive system—cervical cancer	0.00265	0.0117	CbGeAlD
Tamoxifen—ESRRA—female reproductive system—cervical cancer	0.00261	0.0116	CbGeAlD
Tamoxifen—Cramp muscle—Topotecan—cervical cancer	0.00255	0.0139	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00255	0.0139	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00249	0.0137	CcSEcCtD
Tamoxifen—DHCR7—female gonad—cervical cancer	0.00241	0.0107	CbGeAlD
Tamoxifen—FMO1—female gonad—cervical cancer	0.00241	0.0107	CbGeAlD
Tamoxifen—DHCR7—vagina—cervical cancer	0.0024	0.0106	CbGeAlD
Tamoxifen—FMO1—vagina—cervical cancer	0.0024	0.0106	CbGeAlD
Tamoxifen—ESRRA—female gonad—cervical cancer	0.00238	0.0105	CbGeAlD
Tamoxifen—ESRRA—vagina—cervical cancer	0.00236	0.0105	CbGeAlD
Tamoxifen—Pancytopenia—Topotecan—cervical cancer	0.00232	0.0127	CcSEcCtD
Tamoxifen—Neutropenia—Topotecan—cervical cancer	0.00228	0.0125	CcSEcCtD
Tamoxifen—Weight increased—Topotecan—cervical cancer	0.00222	0.0122	CcSEcCtD
Tamoxifen—Pneumonia—Topotecan—cervical cancer	0.00219	0.012	CcSEcCtD
Tamoxifen—SULT1A1—lymph node—cervical cancer	0.00218	0.00966	CbGeAlD
Tamoxifen—ESR2—epithelium—cervical cancer	0.00211	0.00934	CbGeAlD
Tamoxifen—SULT1A1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.0021	0.0583	CbGpPWpGaD
Tamoxifen—ESR2—uterine cervix—cervical cancer	0.00209	0.00926	CbGeAlD
Tamoxifen—Sweating—Topotecan—cervical cancer	0.00209	0.0114	CcSEcCtD
Tamoxifen—FMO3—vagina—cervical cancer	0.00207	0.00918	CbGeAlD
Tamoxifen—Haemoglobin—Topotecan—cervical cancer	0.00197	0.0108	CcSEcCtD
Tamoxifen—ESR2—renal system—cervical cancer	0.00196	0.00867	CbGeAlD
Tamoxifen—Haemorrhage—Topotecan—cervical cancer	0.00196	0.0107	CcSEcCtD
Tamoxifen—Hypoaesthesia—Topotecan—cervical cancer	0.00195	0.0107	CcSEcCtD
Tamoxifen—Pharyngitis—Topotecan—cervical cancer	0.00194	0.0106	CcSEcCtD
Tamoxifen—ESR2—endometrium—cervical cancer	0.00189	0.00838	CbGeAlD
Tamoxifen—CES1—female reproductive system—cervical cancer	0.00181	0.00802	CbGeAlD
Tamoxifen—ESRRA—Nuclear Receptors—RARB—cervical cancer	0.00179	0.0497	CbGpPWpGaD
Tamoxifen—ESR2—uterus—cervical cancer	0.00174	0.00772	CbGeAlD
Tamoxifen—Alopecia—Topotecan—cervical cancer	0.00173	0.00946	CcSEcCtD
Tamoxifen—CES1—female gonad—cervical cancer	0.00165	0.00729	CbGeAlD
Tamoxifen—Back pain—Topotecan—cervical cancer	0.00165	0.00902	CcSEcCtD
Tamoxifen—Muscle spasms—Topotecan—cervical cancer	0.00164	0.00896	CcSEcCtD
Tamoxifen—SIGMAR1—uterine cervix—cervical cancer	0.00162	0.00718	CbGeAlD
Tamoxifen—Anaemia—Topotecan—cervical cancer	0.00157	0.00862	CcSEcCtD
Tamoxifen—ESR2—female reproductive system—cervical cancer	0.00157	0.00694	CbGeAlD
Tamoxifen—Angioedema—Topotecan—cervical cancer	0.00156	0.00852	CcSEcCtD
Tamoxifen—DHCR7—lymph node—cervical cancer	0.00155	0.00687	CbGeAlD
Tamoxifen—FMO1—lymph node—cervical cancer	0.00155	0.00687	CbGeAlD
Tamoxifen—SIGMAR1—decidua—cervical cancer	0.00154	0.00684	CbGeAlD
Tamoxifen—ESRRA—lymph node—cervical cancer	0.00153	0.00677	CbGeAlD
Tamoxifen—Leukopenia—Topotecan—cervical cancer	0.00152	0.00835	CcSEcCtD
Tamoxifen—CYP19A1—endometrium—cervical cancer	0.00149	0.0066	CbGeAlD
Tamoxifen—Cough—Topotecan—cervical cancer	0.00149	0.00814	CcSEcCtD
Tamoxifen—ABCC2—renal system—cervical cancer	0.00147	0.00652	CbGeAlD
Tamoxifen—CYP1B1—decidua—cervical cancer	0.00147	0.0065	CbGeAlD
Tamoxifen—SIGMAR1—endometrium—cervical cancer	0.00147	0.00649	CbGeAlD
Tamoxifen—Arthralgia—Topotecan—cervical cancer	0.00145	0.00794	CcSEcCtD
Tamoxifen—Myalgia—Topotecan—cervical cancer	0.00145	0.00794	CcSEcCtD
Tamoxifen—Chest pain—Topotecan—cervical cancer	0.00145	0.00794	CcSEcCtD
Tamoxifen—ESR1—epithelium—cervical cancer	0.00145	0.0064	CbGeAlD
Tamoxifen—CYP1B1—renal system—cervical cancer	0.00144	0.00639	CbGeAlD
Tamoxifen—ESR1—uterine cervix—cervical cancer	0.00143	0.00635	CbGeAlD
Tamoxifen—Discomfort—Topotecan—cervical cancer	0.00143	0.00784	CcSEcCtD
Tamoxifen—ESR2—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00143	0.0397	CbGpPWpGaD
Tamoxifen—ESR2—female gonad—cervical cancer	0.00143	0.00632	CbGeAlD
Tamoxifen—CYP2A6—vagina—cervical cancer	0.00143	0.00631	CbGeAlD
Tamoxifen—SIGMAR1—mammalian vulva—cervical cancer	0.00142	0.00628	CbGeAlD
Tamoxifen—ESR2—vagina—cervical cancer	0.00142	0.00628	CbGeAlD
Tamoxifen—ESRRA—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00142	0.0393	CbGpPWpGaD
Tamoxifen—Infection—Topotecan—cervical cancer	0.00138	0.00756	CcSEcCtD
Tamoxifen—CYP19A1—uterus—cervical cancer	0.00137	0.00608	CbGeAlD
Tamoxifen—ESR1—decidua—cervical cancer	0.00137	0.00605	CbGeAlD
Tamoxifen—Thrombocytopenia—Topotecan—cervical cancer	0.00136	0.00745	CcSEcCtD
Tamoxifen—SIGMAR1—uterus—cervical cancer	0.00135	0.00598	CbGeAlD
Tamoxifen—CES1—E2F transcription factor network—YY1—cervical cancer	0.00134	0.0373	CbGpPWpGaD
Tamoxifen—Hyperhidrosis—Topotecan—cervical cancer	0.00134	0.00736	CcSEcCtD
Tamoxifen—FMO3—lymph node—cervical cancer	0.00134	0.00594	CbGeAlD
Tamoxifen—ESR1—renal system—cervical cancer	0.00134	0.00594	CbGeAlD
Tamoxifen—Anorexia—Topotecan—cervical cancer	0.00132	0.00725	CcSEcCtD
Tamoxifen—ESR1—endometrium—cervical cancer	0.0013	0.00574	CbGeAlD
Tamoxifen—CYP1B1—uterus—cervical cancer	0.00128	0.00569	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00127	0.00693	CcSEcCtD
Tamoxifen—Paraesthesia—Topotecan—cervical cancer	0.00125	0.00683	CcSEcCtD
Tamoxifen—Dyspnoea—Topotecan—cervical cancer	0.00124	0.00678	CcSEcCtD
Tamoxifen—CYP19A1—female reproductive system—cervical cancer	0.00124	0.00547	CbGeAlD
Tamoxifen—Dyspepsia—Topotecan—cervical cancer	0.00122	0.0067	CcSEcCtD
Tamoxifen—Decreased appetite—Topotecan—cervical cancer	0.00121	0.00662	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Topotecan—cervical cancer	0.0012	0.00657	CcSEcCtD
Tamoxifen—Fatigue—Topotecan—cervical cancer	0.0012	0.00656	CcSEcCtD
Tamoxifen—ESR1—uterus—cervical cancer	0.00119	0.00529	CbGeAlD
Tamoxifen—Pain—Topotecan—cervical cancer	0.00119	0.00651	CcSEcCtD
Tamoxifen—Constipation—Topotecan—cervical cancer	0.00119	0.00651	CcSEcCtD
Tamoxifen—ABCC2—female reproductive system—cervical cancer	0.00118	0.00522	CbGeAlD
Tamoxifen—CYP1B1—female reproductive system—cervical cancer	0.00116	0.00511	CbGeAlD
Tamoxifen—ABCG2—uterine cervix—cervical cancer	0.00115	0.00508	CbGeAlD
Tamoxifen—ESR2—Nuclear Receptors—RARB—cervical cancer	0.00114	0.0316	CbGpPWpGaD
Tamoxifen—Gastrointestinal pain—Topotecan—cervical cancer	0.00114	0.00622	CcSEcCtD
Tamoxifen—CYP19A1—female gonad—cervical cancer	0.00112	0.00498	CbGeAlD
Tamoxifen—SIGMAR1—female gonad—cervical cancer	0.00111	0.00489	CbGeAlD
Tamoxifen—CYP2C8—renal system—cervical cancer	0.0011	0.00489	CbGeAlD
Tamoxifen—Urticaria—Topotecan—cervical cancer	0.0011	0.00605	CcSEcCtD
Tamoxifen—CYP1A1—epithelium—cervical cancer	0.0011	0.00487	CbGeAlD
Tamoxifen—SIGMAR1—vagina—cervical cancer	0.0011	0.00486	CbGeAlD
Tamoxifen—Abdominal pain—Topotecan—cervical cancer	0.0011	0.00602	CcSEcCtD
Tamoxifen—ABCG2—decidua—cervical cancer	0.00109	0.00484	CbGeAlD
Tamoxifen—CYP1A1—uterine cervix—cervical cancer	0.00109	0.00482	CbGeAlD
Tamoxifen—CES1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00108	0.0301	CbGpPWpGaD
Tamoxifen—ESR1—female reproductive system—cervical cancer	0.00107	0.00475	CbGeAlD
Tamoxifen—CYP2C8—endometrium—cervical cancer	0.00107	0.00473	CbGeAlD
Tamoxifen—CYP3A5—uterine cervix—cervical cancer	0.00107	0.00472	CbGeAlD
Tamoxifen—CES1—lymph node—cervical cancer	0.00106	0.00469	CbGeAlD
Tamoxifen—CYP1B1—female gonad—cervical cancer	0.00105	0.00465	CbGeAlD
Tamoxifen—ABCG2—endometrium—cervical cancer	0.00104	0.0046	CbGeAlD
Tamoxifen—CYP1A2—renal system—cervical cancer	0.00103	0.00458	CbGeAlD
Tamoxifen—Hypersensitivity—Topotecan—cervical cancer	0.00102	0.00561	CcSEcCtD
Tamoxifen—CYP1A1—renal system—cervical cancer	0.00102	0.00451	CbGeAlD
Tamoxifen—ABCG2—mammalian vulva—cervical cancer	0.001	0.00445	CbGeAlD
Tamoxifen—CYP3A5—renal system—cervical cancer	0.000997	0.00441	CbGeAlD
Tamoxifen—Asthenia—Topotecan—cervical cancer	0.000997	0.00546	CcSEcCtD
Tamoxifen—CYP2B6—renal system—cervical cancer	0.000991	0.00439	CbGeAlD
Tamoxifen—Pruritus—Topotecan—cervical cancer	0.000983	0.00538	CcSEcCtD
Tamoxifen—ESR1—female gonad—cervical cancer	0.000977	0.00433	CbGeAlD
Tamoxifen—ESR1—vagina—cervical cancer	0.000971	0.0043	CbGeAlD
Tamoxifen—ABCG2—uterus—cervical cancer	0.000957	0.00424	CbGeAlD
Tamoxifen—CYP1A1—mammalian vulva—cervical cancer	0.000953	0.00422	CbGeAlD
Tamoxifen—Diarrhoea—Topotecan—cervical cancer	0.00095	0.00521	CcSEcCtD
Tamoxifen—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00093	0.0258	CbGpPWpGaD
Tamoxifen—CYP2E1—renal system—cervical cancer	0.00093	0.00412	CbGeAlD
Tamoxifen—Dizziness—Topotecan—cervical cancer	0.000919	0.00503	CcSEcCtD
Tamoxifen—ESR2—lymph node—cervical cancer	0.000917	0.00406	CbGeAlD
Tamoxifen—CYP2C19—vagina—cervical cancer	0.000917	0.00406	CbGeAlD
Tamoxifen—CYP1A1—uterus—cervical cancer	0.000908	0.00402	CbGeAlD
Tamoxifen—ESR2—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000901	0.025	CbGpPWpGaD
Tamoxifen—CYP2C8—female reproductive system—cervical cancer	0.000885	0.00392	CbGeAlD
Tamoxifen—Vomiting—Topotecan—cervical cancer	0.000883	0.00484	CcSEcCtD
Tamoxifen—Rash—Topotecan—cervical cancer	0.000876	0.0048	CcSEcCtD
Tamoxifen—Dermatitis—Topotecan—cervical cancer	0.000875	0.00479	CcSEcCtD
Tamoxifen—Headache—Topotecan—cervical cancer	0.00087	0.00477	CcSEcCtD
Tamoxifen—Nausea—Topotecan—cervical cancer	0.000825	0.00452	CcSEcCtD
Tamoxifen—CYP1A1—female reproductive system—cervical cancer	0.000817	0.00361	CbGeAlD
Tamoxifen—CYP2C8—vagina—cervical cancer	0.0008	0.00354	CbGeAlD
Tamoxifen—CYP2B6—female reproductive system—cervical cancer	0.000793	0.00351	CbGeAlD
Tamoxifen—CYP2C9—female reproductive system—cervical cancer	0.000786	0.00348	CbGeAlD
Tamoxifen—ABCG2—female gonad—cervical cancer	0.000783	0.00346	CbGeAlD
Tamoxifen—ABCG2—vagina—cervical cancer	0.000778	0.00344	CbGeAlD
Tamoxifen—CES1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000759	0.0211	CbGpPWpGaD
Tamoxifen—CYP3A4—renal system—cervical cancer	0.000748	0.00331	CbGeAlD
Tamoxifen—CYP2E1—female reproductive system—cervical cancer	0.000745	0.0033	CbGeAlD
Tamoxifen—CYP1A1—female gonad—cervical cancer	0.000743	0.00329	CbGeAlD
Tamoxifen—CYP1A1—vagina—cervical cancer	0.000738	0.00327	CbGeAlD
Tamoxifen—CYP2D6—renal system—cervical cancer	0.000736	0.00326	CbGeAlD
Tamoxifen—CYP3A5—female gonad—cervical cancer	0.000726	0.00322	CbGeAlD
Tamoxifen—CYP19A1—lymph node—cervical cancer	0.000723	0.0032	CbGeAlD
Tamoxifen—CYP3A5—vagina—cervical cancer	0.000722	0.0032	CbGeAlD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.000721	0.02	CbGpPWpGaD
Tamoxifen—CYP2B6—vagina—cervical cancer	0.000718	0.00318	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—cervical cancer	0.000711	0.00315	CbGeAlD
Tamoxifen—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000707	0.0196	CbGpPWpGaD
Tamoxifen—ABCC2—lymph node—cervical cancer	0.00069	0.00305	CbGeAlD
Tamoxifen—CYP19A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000676	0.0188	CbGpPWpGaD
Tamoxifen—CYP1B1—lymph node—cervical cancer	0.000676	0.00299	CbGeAlD
Tamoxifen—CYP1B1—Tryptophan metabolism—UBE3A—cervical cancer	0.000651	0.0181	CbGpPWpGaD
Tamoxifen—ESR1—lymph node—cervical cancer	0.000628	0.00278	CbGeAlD
Tamoxifen—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cervical cancer	0.00061	0.0169	CbGpPWpGaD
Tamoxifen—CYP3A4—female reproductive system—cervical cancer	0.000599	0.00265	CbGeAlD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.000597	0.0166	CbGpPWpGaD
Tamoxifen—CYP2D6—female reproductive system—cervical cancer	0.00059	0.00261	CbGeAlD
Tamoxifen—ESR1—Nuclear Receptors—RARB—cervical cancer	0.000575	0.016	CbGpPWpGaD
Tamoxifen—ABCB1—epithelium—cervical cancer	0.000571	0.00253	CbGeAlD
Tamoxifen—ABCB1—uterine cervix—cervical cancer	0.000566	0.00251	CbGeAlD
Tamoxifen—ABCB1—decidua—cervical cancer	0.000539	0.00239	CbGeAlD
Tamoxifen—UGT1A4—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000538	0.0149	CbGpPWpGaD
Tamoxifen—CYP2D6—female gonad—cervical cancer	0.000537	0.00238	CbGeAlD
Tamoxifen—ABCB1—renal system—cervical cancer	0.00053	0.00234	CbGeAlD
Tamoxifen—ABCB1—endometrium—cervical cancer	0.000512	0.00227	CbGeAlD
Tamoxifen—ABCG2—lymph node—cervical cancer	0.000503	0.00223	CbGeAlD
Tamoxifen—ABCB1—mammalian vulva—cervical cancer	0.000495	0.00219	CbGeAlD
Tamoxifen—CYP1A1—lymph node—cervical cancer	0.000478	0.00211	CbGeAlD
Tamoxifen—ABCB1—uterus—cervical cancer	0.000472	0.00209	CbGeAlD
Tamoxifen—ESR1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000454	0.0126	CbGpPWpGaD
Tamoxifen—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000451	0.0125	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—UBE3A—cervical cancer	0.000443	0.0123	CbGpPWpGaD
Tamoxifen—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000441	0.0123	CbGpPWpGaD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00043	0.0119	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000425	0.0118	CbGpPWpGaD
Tamoxifen—CYP2E1—Tryptophan metabolism—UBE3A—cervical cancer	0.000425	0.0118	CbGpPWpGaD
Tamoxifen—ABCB1—female reproductive system—cervical cancer	0.000424	0.00188	CbGeAlD
Tamoxifen—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000401	0.0111	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00039	0.0108	CbGpPWpGaD
Tamoxifen—ABCB1—female gonad—cervical cancer	0.000386	0.00171	CbGeAlD
Tamoxifen—ABCB1—vagina—cervical cancer	0.000384	0.0017	CbGeAlD
Tamoxifen—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.000366	0.0102	CbGpPWpGaD
Tamoxifen—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000346	0.00961	CbGpPWpGaD
Tamoxifen—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000332	0.00923	CbGpPWpGaD
Tamoxifen—ESR1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000322	0.00893	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000313	0.00869	CbGpPWpGaD
Tamoxifen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00031	0.00862	CbGpPWpGaD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0003	0.00834	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000288	0.008	CbGpPWpGaD
Tamoxifen—CES1—Fluoropyrimidine Activity—TP53—cervical cancer	0.000288	0.008	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000273	0.00758	CbGpPWpGaD
Tamoxifen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000265	0.00736	CbGpPWpGaD
Tamoxifen—CYP19A1—FSH signaling pathway—MTOR—cervical cancer	0.000259	0.0072	CbGpPWpGaD
Tamoxifen—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000256	0.00709	CbGpPWpGaD
Tamoxifen—ABCB1—lymph node—cervical cancer	0.000248	0.0011	CbGeAlD
Tamoxifen—ESRRA—Generic Transcription Pathway—RARB—cervical cancer	0.000244	0.00679	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000242	0.00671	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.00023	0.00638	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—HES1—cervical cancer	0.00022	0.00609	CbGpPWpGaD
Tamoxifen—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000214	0.00593	CbGpPWpGaD
Tamoxifen—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000213	0.00592	CbGpPWpGaD
Tamoxifen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000205	0.00568	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.0002	0.00555	CbGpPWpGaD
Tamoxifen—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000197	0.00547	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000177	0.00493	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000172	0.00478	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—TERT—cervical cancer	0.000172	0.00477	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000162	0.00449	CbGpPWpGaD
Tamoxifen—ESR1—LKB1 signaling events—MTOR—cervical cancer	0.00016	0.00444	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000158	0.00438	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—RARB—cervical cancer	0.000156	0.00432	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—CA9—cervical cancer	0.000142	0.00394	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—CA9—cervical cancer	0.000139	0.00387	CbGpPWpGaD
Tamoxifen—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000136	0.00377	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—CA9—cervical cancer	0.000135	0.00374	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000126	0.00349	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000124	0.00344	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000121	0.00336	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—RARB—cervical cancer	0.000118	0.00327	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000117	0.00325	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—CA9—cervical cancer	0.000116	0.00321	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000114	0.00318	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000114	0.00318	CbGpPWpGaD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000114	0.00317	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000113	0.00314	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000111	0.00309	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—MTOR—cervical cancer	0.000111	0.00308	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—CA9—cervical cancer	0.000108	0.00299	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000106	0.00295	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000104	0.00289	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	0.000104	0.00288	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000103	0.00286	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—MTOR—cervical cancer	0.000102	0.00284	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.0001	0.00278	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—NOTCH1—cervical cancer	0.0001	0.00278	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	9.68e-05	0.00269	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—CTNNB1—cervical cancer	9.6e-05	0.00267	CbGpPWpGaD
Tamoxifen—ESR1—LKB1 signaling events—TP53—cervical cancer	9.43e-05	0.00262	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	9.3e-05	0.00258	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	8.85e-05	0.00246	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	8.53e-05	0.00237	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	8.35e-05	0.00232	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FGFR3—cervical cancer	8.28e-05	0.0023	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—CA9—cervical cancer	8.28e-05	0.0023	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	7.95e-05	0.00221	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—STAT3—cervical cancer	7.92e-05	0.0022	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—RARB—cervical cancer	7.84e-05	0.00218	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—NOTCH2—cervical cancer	7.8e-05	0.00216	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—EGFR—cervical cancer	7.79e-05	0.00216	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—RARB—cervical cancer	7.49e-05	0.00208	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	7.12e-05	0.00198	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	7.05e-05	0.00196	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	7.05e-05	0.00196	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CA9—cervical cancer	6.94e-05	0.00193	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	6.76e-05	0.00188	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	6.54e-05	0.00182	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—cervical cancer	6.39e-05	0.00177	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—NOTCH1—cervical cancer	6.38e-05	0.00177	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—CASP8—cervical cancer	6.32e-05	0.00176	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	6.02e-05	0.00167	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	5.9e-05	0.00164	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	5.85e-05	0.00163	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—MTOR—cervical cancer	5.82e-05	0.00162	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	5.8e-05	0.00161	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—MTHFR—cervical cancer	5.76e-05	0.0016	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.67e-05	0.00158	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—MTHFR—cervical cancer	5.66e-05	0.00157	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—MTHFR—cervical cancer	5.46e-05	0.00152	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	5.39e-05	0.00149	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—NOTCH2—cervical cancer	5.2e-05	0.00144	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	5.19e-05	0.00144	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CA9—cervical cancer	5.11e-05	0.00142	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—NOTCH2—cervical cancer	4.96e-05	0.00138	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—NOTCH1—cervical cancer	4.83e-05	0.00134	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—CASP3—cervical cancer	4.78e-05	0.00133	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—MTHFR—cervical cancer	4.7e-05	0.0013	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	4.59e-05	0.00128	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	4.5e-05	0.00125	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	4.5e-05	0.00125	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.46e-05	0.00124	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—MTHFR—cervical cancer	4.37e-05	0.00121	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4.3e-05	0.00119	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	4.11e-05	0.00114	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—EGFR—cervical cancer	4.09e-05	0.00114	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TAAR6—cervical cancer	3.92e-05	0.00109	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CA9—cervical cancer	3.86e-05	0.00107	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—cervical cancer	3.86e-05	0.00107	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—RARB—cervical cancer	3.78e-05	0.00105	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CA9—cervical cancer	3.71e-05	0.00103	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—cervical cancer	3.45e-05	0.000959	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.41e-05	0.000946	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CA9—cervical cancer	3.38e-05	0.000938	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—MTHFR—cervical cancer	3.36e-05	0.000932	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CA9—cervical cancer	3.35e-05	0.00093	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—NOTCH1—cervical cancer	3.22e-05	0.000893	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	3.12e-05	0.000866	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—NOTCH1—cervical cancer	3.07e-05	0.000852	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CA9—cervical cancer	3.07e-05	0.000852	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—WNT2—cervical cancer	3.06e-05	0.000849	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.86e-05	0.000794	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—MTHFR—cervical cancer	2.81e-05	0.000781	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKAP13—cervical cancer	2.68e-05	0.000745	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—NOTCH2—cervical cancer	2.5e-05	0.000694	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CA9—cervical cancer	2.48e-05	0.000688	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CA9—cervical cancer	2.43e-05	0.000674	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CA9—cervical cancer	2.42e-05	0.000672	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	2.36e-05	0.000655	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—WNT5A—cervical cancer	2.32e-05	0.000643	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CA9—cervical cancer	2.29e-05	0.000635	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	2.28e-05	0.000632	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CA9—cervical cancer	2.1e-05	0.000582	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—MTHFR—cervical cancer	2.07e-05	0.000576	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CA9—cervical cancer	1.87e-05	0.00052	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CA9—cervical cancer	1.83e-05	0.000507	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.8e-05	0.0005	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CA9—cervical cancer	1.72e-05	0.000478	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CA9—cervical cancer	1.71e-05	0.000474	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH2—cervical cancer	1.63e-05	0.000452	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—MTHFR—cervical cancer	1.57e-05	0.000435	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—NOTCH1—cervical cancer	1.55e-05	0.00043	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.51e-05	0.00042	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—MTHFR—cervical cancer	1.51e-05	0.000418	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CA9—cervical cancer	1.46e-05	0.000405	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—MTHFR—cervical cancer	1.37e-05	0.000381	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—MTHFR—cervical cancer	1.36e-05	0.000377	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HES1—cervical cancer	1.33e-05	0.00037	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MTHFR—cervical cancer	1.25e-05	0.000346	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TERT—cervical cancer	1.17e-05	0.000324	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CA9—cervical cancer	1.13e-05	0.000313	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGFR3—cervical cancer	1.07e-05	0.000298	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH1—cervical cancer	1.01e-05	0.000279	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MTHFR—cervical cancer	1.01e-05	0.000279	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MTHFR—cervical cancer	9.85e-06	0.000273	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MTHFR—cervical cancer	9.83e-06	0.000273	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MTHFR—cervical cancer	9.28e-06	0.000258	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MTHFR—cervical cancer	8.51e-06	0.000236	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—cervical cancer	7.6e-06	0.000211	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MTOR—cervical cancer	7.54e-06	0.000209	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—cervical cancer	7.41e-06	0.000206	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—cervical cancer	6.99e-06	0.000194	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—cervical cancer	6.94e-06	0.000193	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—cervical cancer	6.93e-06	0.000192	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—cervical cancer	6.69e-06	0.000186	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—cervical cancer	5.92e-06	0.000164	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—cervical cancer	5.83e-06	0.000162	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—cervical cancer	5.3e-06	0.000147	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—cervical cancer	4.57e-06	0.000127	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—cervical cancer	4.45e-06	0.000124	CbGpPWpGaD
